| 23-May-13 11:06AM | 2 Biotechs to Avoid, 1 to Buy at Motley Fool |
| 22-May-13 07:00AM | Cubist, Optimer, Trius: Antibiotic Deal Making On Tap at TheStreet |
| 17-May-13 01:04PM | OPTIMER PHARMACEUTICALS INC Financials EDGAR Online Financials |
| 15-May-13 05:19PM | Cubist bid for Optimer before sale process began-sources at Reuters +13.54% |
| 04:08PM | Cubist bid almost $1 billion for Optimer before sale process: sources at Reuters |
| 03:47PM | Cubist bid almost $1 bln for Optimer before sale process-sources at Reuters |
| 10:08AM | Is AstraZeneca Gearing Up for a Shopping Spree? at Motley Fool |
| 14-May-13 06:02PM | Nasdaq stocks posting largest percentage increases AP |
| 02:11PM | Nasdaq stocks posting largest percentage increases AP |
| 10:23AM | Markman Hearing A Likely Clearing Event For Cubist - Decision Any Day at Seeking Alpha |
| 10:08AM | AstraZeneca, Cubist, Astellas Said to Bid for Optimer at Bloomberg |
| 13-May-13 06:03PM | Nasdaq stocks posting largest percentage increases AP +14.44% |
| 04:53PM | Optimer gets bids from AstraZeneca, Cubist, Astellas, Bloomberg says theflyonthewall.com |
| 04:11PM | AstraZeneca, Cubist, Astellas Said to Make Bids for Optimer at Bloomberg |
| 04:04PM | InPlay: Optimer Pharma appoints Eric Sirota as Chief Operating Officer Briefing.com |
| 04:04PM | Optimer Pharmaceuticals Appoints Eric Sirota as Chief Operating Officer PR Newswire |
| 03:06PM | 3 Biotech Stocks Spiking With Big Volume at TheStreet |
| 01:18PM | Nasdaq stocks posting largest percentage decreases AP |
| 10:13AM | OPTIMER PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Pr EDGAR Online |
| 12-May-13 11:55AM | Investors are Digesting These Healthcare Stock Earnings Insights at Wall St. Cheat Sheet |
| 11-May-13 10:07AM | The Best- And Worst-Performing Biotech Stocks, May 3 To May 10 at Forbes |
| 10-May-13 06:10PM | Optimer Pharmaceuticals Misses on the Top and Bottom Lines at Motley Fool -14.14% |
| 06:02PM | Nasdaq stocks posting largest percentage decreases AP |
| 01:48PM | Why Optimer Pharmaceuticals Shares Sank at Motley Fool |
| 01:20PM | Nasdaq stocks posting largest percentage decreases AP |
| 11:40AM | Wider-than-Expected Loss at Optimer Zacks |
| 06:17AM | Optimer downgraded to Neutral from Outperform at RW Baird theflyonthewall.com |
| 09-May-13 11:06PM | OPTIMER PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 10:13PM | Optimer Pharma downgraded by Robert W. Baird and Needham Briefing.com |
| 09:01PM | Optimer Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha |
| 06:25PM | Optimer Pharmaceuticals Earnings: Everything You Must Know Now at Wall St. Cheat Sheet |
| 04:04PM | InPlay: Optimer Pharma misses by $0.19, misses on revs Briefing.com |
| 04:02PM | Optimer Reports First Quarter 2013 Financial Results PR Newswire |
| 09:11AM | OPTIMER PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Submission of Matters EDGAR Online |
| 07:07AM | Q1 2013 Optimer Pharmaceuticals Inc Earnings Release - After Market Close CCBN |
| 08-May-13 09:33AM | OPTIMER PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online |
| 05-May-13 01:23PM | Predicting Biotech Stock Moves Using Top Consensus Picks By Legendary Fund Managers at Seeking Alpha |
| 02-May-13 08:20AM | The Zacks Analyst Blog Highlights: AT&T, Optimer Pharmaceuticals, ViroPharma, Astellas Pharma and Incyte Zacks |
| 08:00AM | Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2013 Financial Results PR Newswire |
| 01-May-13 05:00PM | Optimer's Dificid Cleared Down Under Zacks |
| 29-Apr-13 11:07AM | Sarepta (SRPT) Targets Unmet Medical Need in the Treatment of Duchenne Muscular Dystrophy; Developing First Drug with the Promise of Stopping Fatal Progressive Disease Wall Street Transcript |
| 26-Apr-13 08:01AM | InPlay: Optimer Pharma announced that DIFICID tablets were Approved in Australia Briefing.com |
| 08:00AM | DIFICID® (fidaxomicin) Tablets Approved in Australia PR Newswire |
| 19-Apr-13 08:50AM | 1Q Earnings Beat at Cubist Pharma Zacks |
| 16-Apr-13 10:50AM | Will Cubist Pharma Beat Earnings? Zacks |
| 08-Apr-13 07:40AM | Last Week's Best- And Worst-Performing Medical Stocks at Forbes |
| 06-Apr-13 12:30PM | This Week in Biotech at Motley Fool |
| 10:19AM | 3 Humongous Health-Care Stocks This Week at Motley Fool |
| 03-Apr-13 06:06PM | Nasdaq stocks posting largest percentage increases AP |
| 01:37PM | Nasdaq stocks posting largest percentage increases AP |
| 11:51AM | Cubist named as possible suitor for Optimer at bizjournals.com |
| 02-Apr-13 06:08PM | Nasdaq stocks posting largest percentage increases AP +19.19% |
| 05:14PM | Is This Really Big Pharma's Next Acquisition? at Motley Fool |
| 05:14PM | 1 Biotech's Unexpected Bidding War at Motley Fool |
| 04:25PM | Optimer Said to Draw Takeover Interest From Glaxo at Bloomberg |
| 03:21PM | Nasdaq stocks posting largest percentage increases AP |
| 03:18PM | 4 Merger and Acquisitions Stock Stories for Tuesday Appraisal at Wall St. Cheat Sheet |
| 02:30PM | Optimer shares rise after report names Glaxo, Cubist as potential buyers at Reuters |
| 02:01PM | Optimer Pharmaceuticals Shares Soar... for the Right Price, That Is! at Motley Fool |
| 09:39AM | Optimer Said to Draw Takeover Interest From Glaxo, Astellas at Bloomberg |
| 09:37AM | Optimer jumps 24% after Bloomberg says company draws bidding interest at theflyonthewall.com |
| 09:36AM | Optimer draws interest from Cubist, AstraZeneca, Glaxo, Bloomberg says at theflyonthewall.com |
| 22-Mar-13 01:04PM | OPTIMER PHARMACEUTICALS INC Financials EDGAR Online Financials |
| 18-Mar-13 09:41AM | OPTIMER PHARMACEUTICALS INC Files SEC form 10-K, Annual Report EDGAR Online |
| 15-Mar-13 08:00AM | Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire |
| 06-Mar-13 11:43AM | Why Optimer Pharmaceuticals Is Poised to Pull Back at Motley Fool |
| 04-Mar-13 02:28PM | Optimer Posts Wider Loss Zacks |
| 12:01PM | This Week in Biotech at Motley Fool |
| 02-Mar-13 09:11PM | New Star Analyst Rankings for Optimer Pharmaceuticals, Inc. StarMine |
| 01-Mar-13 07:31PM | 3 Humongous Health-Care Stocks This Week at Motley Fool |
| 07:30PM | New Star Analyst Rankings for Optimer Pharmaceuticals, Inc. StarMine |
| 04:28PM | Encouraging News for Cubist Pharma Zacks |
| 02:35PM | Optimer Pharmaceuticals Beats on Both Top and Bottom Lines at Motley Fool |
| 28-Feb-13 08:50PM | Optimer Pharmaceuticals Management Discusses Q4 2012 Results - Earnings Call Transcript at Seeking Alpha |
| 06:15PM | Optimer Pharmaceuticals Earnings: Everything You Must Know Now at Wall St. Cheat Sheet |
| 05:25PM | OPTIMER PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financia EDGAR Online |
| 04:06PM | Optimer Reports Fourth Quarter and Fiscal Year 2012 Financial Results PR Newswire |
| 01:00PM | Pandora Still a Strong Outperform and 4 Analyst Notes to Know at Wall St. Cheat Sheet |
| 07:07AM | Q4 2012 Optimer Pharmaceuticals Inc Earnings Release - After Market Close CCBN |
| 27-Feb-13 06:08PM | Can Optimer Optimize Shareholder Returns? at Motley Fool +13.15% |
| 05:29PM | OPTIMER PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations and EDGAR Online |
| 04:13PM | Cave Explorer Hunts Antibiotics 1,600 Feet Down: Health at Bloomberg |
| 04:08PM | Optimer Consider Strategic Alternatives as CEO Steps Down at Bloomberg |
| 02:31PM | 3 Biotech Stocks Rising on Big Volume at TheStreet |
| 12:29PM | Optimer Consider Strategic Alternatives as CEO Steps Down at Bloomberg |
| 12:06PM | Why Optimer Pharmaceuticals Shares Soared at Motley Fool |
| 11:09AM | Optimer Pharma exploring sale, shares jump at Reuters |
| 10:42AM | Optimer Consider Strategic Alternatives as CEO Steps Down at Bloomberg |
| 10:25AM | Optimer board to review strategic alternatives AP |
| 10:04AM | Cave Explorer Hunts Antibiotics 1,600 Feet Down: Health at Bloomberg |
| 08:24AM | Optimer Pharma exploring sale, shares jump at Reuters |
| 08:15AM | Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire |
| 08:13AM | Optimer as adopted a Rights Plan that expires February 15, 2014 theflyonthewall.com |
| 08:09AM | Optimer announced it will begin to explore full range of strategic alternatives theflyonthewall.com |
| 08:03AM | InPlay: Optimer Pharma's Board of Directors Appoints Board Chairman, Dr. Henry McKinnell, Chief Executive Officer; announces it has commenced process to explore strategic alternatices Briefing.com |
| 08:00AM | Optimer Pharmaceuticals' Board of Directors Appoints Board Chairman, Dr. Henry McKinnell, Chief Executive Officer PR Newswire |
| 12:01AM | Cave Explorer Hunts Antibiotics 1,600 Feet Down: Health at Bloomberg |
| 26-Feb-13 04:53PM | Cubist Pharma Inks Deal Zacks |
| 25-Feb-13 01:13AM | What Does Wall Street See for Optimer Pharmaceuticals's Q4? at Motley Fool |
| 21-Feb-13 11:56AM | Steer Clear Of Optimer's Short And Long-Term Risks at Seeking Alpha |
